NASDAQ:LYEL | Total Assets | Lyell Immunopharma, Inc.

Complete source-backed total assets history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Total Assets

DateTotal assetsCurrent assetsCash and equivalentsCurrent securitiesReceivablesInventoryProperty, plant and equipmentOther noncurrent assets
2026-06-30$311.15M$213.54M$72.99M$131.12M$30.51M$5.84M
2026-03-31$350.63M$267.3M$90.77M$163.25M$32.72M$5.23M
2025-12-31$340.05M$260.94M$60.18M$187.04M$34.77M$4.89M
2025-09-30$407.97M$328.2M$123.58M$196.05M$36.72M$2.55M
2025-06-30$385.45M$282.21M$98.8M$177.99M$39.12M$2.53M
2025-03-31$429.8M$309.18M$120.33M$180.85M$44.2M$3.22M
2024-12-31$490.86M$379.59M$105.6M$264.93M$48.2M$4.62M
2024-09-30$619.22M$450.05M$100.3M$340.25M$88.05M$5.06M
2024-06-30$654.14M$499.82M$133.42M$357.7M$93.1M$4.24M
2024-03-31$694.22M$534.17M$125.65M$400.65M$97.84M$4.24M
2023-12-31$750.03M$554.69M$145.65M$400.58M$102.65M$4.24M
2023-09-30$794.99M$586.85M$286.21M$289.22M$108.1M$4.42M
2023-06-30$835.35M$606.41M$224.37M$371.38M$113.68M$4.52M
2023-03-31$880.45M$624.4M$109.43M$503.34M$118.6M$4.6M
2022-12-31$937.56M$651.3M$123.55M$516.6M$123.02M$4.68M
2022-09-30$977.27M$659.75M$116.31M$531.82M$125.73M$2.91M
2022-06-30$1.02B$666.78M$205.74M$449.83M$127.56M$3.71M
2022-03-31$1.07B$625.71M$222.6M$391.32M$125.71M$3.57M
2021-12-31$1.13B$626.29M$293.83M$320.97M$120.1M$3.48M
2021-09-30$1.2B$631.15M$393.5M$225.42M$115.86M$2.67M
2021-06-30$1.23B$834.84M$564.44M$260.08M$109.64M$2.79M
2021-03-31$244.37M
2020-12-31$908.28M$617.55M$140.41M$472.21M$77.05M$2.77M
2020-09-30$134.41M
2020-06-30$245.95M
2019-12-31$96.67M
2018-12-31$130.28M